Direct Genetics Referral Pathway for High-Grade Serous Ovarian Cancer Patients: The "Opt-Out" Process.

Jacob McGeeTeresa M PeartNorine FoleyMonique BertrandMichel PrefontaineAkira SugimotoHelen EttlerStephen WelchKaren Panabaker

Published in: Journal of oncology (2019)

The opt-out referral process described in this study is s a feasible, effective, and patient-centred approach to increase access to BRCA1/2 testing for patients with ovarian cancer.

Keyphrases

high grade
end stage renal disease
primary care
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
case report